Lan Ma

Hubei Key Laboratory Of Tumor Microenvironment And Immunotherapy
Xiaoxita, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

From Antibody Drugs to RNA Interference and Nanotherapy: The Evolution and Integration of Targeted Strategies in Gastric Cancer.

From Antibody Drugs to RNA Interference and Nanotherapy: The Evolution and Integration of Targeted Strategies in Gastric Cancer.

Journal: International journal of nanomedicine

Published: April 22, 2026

How PLGA Microspheres are Emerging as a Key Drug Delivery System.

How PLGA Microspheres are Emerging as a Key Drug Delivery System.

Journal: International journal of nanomedicine

Published: January 30, 2026

Liposome stability: multifactorial regulation and optimization strategies in in vivo delivery.

Liposome stability: multifactorial regulation and optimization strategies in in vivo delivery.

Journal: Journal of liposome research

Published: September 22, 2025

GP73 inhibition alleviates hepatic fibrosis by suppressing TGF-β/mTOR signaling pathways.

GP73 inhibition alleviates hepatic fibrosis by suppressing TGF-β/mTOR signaling pathways.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 01, 2025

Immunogenic Cell Death-Associated miRNAs in the Tumor Microenvironment of Hepatocellular Carcinoma.

Immunogenic Cell Death-Associated miRNAs in the Tumor Microenvironment of Hepatocellular Carcinoma.

Journal: Journal of surgical oncology

Published: June 20, 2025

Hepatic-stellate-cell-targeted delivery of PU.1 decoy ODN by Apt-Tan attenuates liver fibrosis in mice.

Hepatic-stellate-cell-targeted delivery of PU.1 decoy ODN by Apt-Tan attenuates liver fibrosis in mice.

Journal: Molecular therapy. Nucleic acids

Published: August 03, 2024

Targeted APT8(16-34) obtained by cell-SELEX and its internalization with miR-23-5p into activated hepatic stellate cells.

Targeted APT8(16-34) obtained by cell-SELEX and its internalization with miR-23-5p into activated hepatic stellate cells.

Journal: Hepatology international

Published: August 01, 2024

The Application of Aptamer and Research Progress in Liver Disease.

The Application of Aptamer and Research Progress in Liver Disease.

Journal: Molecular biotechnology

Published: September 26, 2023

Current Status and Challenges of Aptamers Screening and Optimization.

Current Status and Challenges of Aptamers Screening and Optimization.

Journal: Combinatorial chemistry & high throughput screening

Published: November 25, 2021

The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells.

The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells.

Journal: Cellular and molecular gastroenterology and hepatology

Published: October 04, 2021

Honokiol exerts protective effects on neural myelin sheaths after compressed spinal cord injury by inhibiting oligodendrocyte apoptosis through regulation of ER-mitochondrial interactions.

Honokiol exerts protective effects on neural myelin sheaths after compressed spinal cord injury by inhibiting oligodendrocyte apoptosis through regulation of ER-mitochondrial interactions.

Journal: The journal of spinal cord medicine

Published: April 08, 2021

Relationship between the structure and function of the transcriptional regulator E2A.

Relationship between the structure and function of the transcriptional regulator E2A.

Journal: Journal of biological research (Thessalonike, Greece)

Published: January 07, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026